STOCK TITAN

HUTCHMED (HCM) submits Form 6-K on acting chief executive officer role

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

HUTCHMED (CHINA) LIMITED filed a Form 6-K as a foreign private issuer, indicating that it uses Form 20-F for its annual reports. The filing mainly serves as a cover for two exhibits: an announcement and a press release, each relating to the appointment of an acting chief executive officer. The document is signed on behalf of the company by Chief Financial Officer Johnny Cheng, confirming the company’s authorization of this disclosure.

Positive

  • None.

Negative

  • None.

Insights

HUTCHMED files a 6-K covering materials on appointing an acting CEO, signaling a leadership transition event.

HUTCHMED (CHINA) LIMITED, a foreign private issuer using Form 20-F for annual reports, has submitted a Form 6-K that forwards two exhibits tied to the appointment of an acting chief executive officer. One exhibit is an announcement and the other is a press release, both focused on this leadership change.

The text provided does not describe who is being appointed, when the appointment is effective, or why the role is designated as “acting.” It simply confirms that the company has formally documented and shared this development, with Chief Financial Officer Johnny Cheng signing the report on the company’s behalf.

Future company communications or subsequent SEC submissions may give more detail on the acting chief executive officer’s identity, responsibilities, and the duration of the acting role, which would help investors better understand any longer-term governance implications.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did HUTCHMED (HCM) file in this Form 6-K?

HUTCHMED (CHINA) LIMITED filed a Form 6-K as a foreign private issuer, serving mainly as a cover for exhibits related to the appointment of an acting chief executive officer.

What is the main subject of HUTCHMED (HCM)'s August 2025 Form 6-K?

The main subject is an appointment of an acting chief executive officer, with the 6-K providing an announcement and a press release that relate to this leadership change.

Which exhibits are included with HUTCHMED (HCM)'s Form 6-K?

The filing lists Exhibit 99.1 as an announcement relating to the appointment of an acting chief executive officer and Exhibit 99.2 as a press release relating to the same topic.

Who signed the HUTCHMED (HCM) Form 6-K?

The Form 6-K was signed on behalf of HUTCHMED (CHINA) LIMITED by Johnny Cheng, who is identified as the company’s chief financial officer.

Does HUTCHMED (HCM) report annually on Form 20-F or Form 40-F?

The document indicates that HUTCHMED (CHINA) LIMITED files its annual reports on Form 20-F, not Form 40-F.

Does this HUTCHMED (HCM) Form 6-K include the full details of the acting CEO appointment?

The text provided shows only the cover and exhibit index; the detailed information appears in Exhibits 99.1 and 99.2, which are referenced but not included in the excerpt.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the Month of August 2025

Commission File Number: 001-37710


HUTCHMED (CHINA) LIMITED

(Translation of registrant’s name into English)


48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong

(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F               Form 40-F  


HUTCHMED (CHINA) LIMITED

Form 6-K

EXHIBIT INDEX

Exhibit No.

    

Description

Exhibit 99.1

Announcement relating to appointment of acting chief executive officer

Exhibit 99.2

Press release relating to appointment of acting chief executive officer

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

HUTCHMED (CHINA) LIMITED

By:

/s/ Johnny Cheng

Name:

Johnny Cheng

Title:

Chief Financial Officer

Date: August 25, 2025

3